Lv1
18 积分 2024-01-02 加入
Molecular insights fast-tracked: AI in biosynthetic pathway research
27天前
已完结
The effectiveness of different non-pharmacological therapies on cancer-related fatigue in cancer patients:A network meta-analysis
2个月前
已完结
The effect of pressure injury prevention care bundles on pressure injuries in hospital patients: A complex intervention systematic review and meta-analysis
2个月前
已完结
In vivo base editing gene therapy for heterozygous familial hypercholesterolemia: a phase 1 trial
2个月前
已完结
Phase 3 study results for oral PCSK9 inhibition with enlicitide
2个月前
已完结
An Oral PCSK9 Inhibitor for Treatment of Hypercholesterolemia
2个月前
已完结
AZD0780, a novel, oral PCSK9 inhibitor with properties allowing for broad use, food-intake independency and co-administration with other lipid lowering therapies
2个月前
已完结
Oral PCSK9 Inhibitor Enlicitide versus Oral Non-statin Therapies: A Phase 3 Randomized Clinical Trial
2个月前
已完结
PCSK9 Promotes LDLR Degradation by Preventing SNX17-Mediated LDLR Recycling
3个月前
已完结
Abstract 4364312: Laroprovstat (AZD0780) an oral, small molecule PCSK9 inhibitor demonstrates improvements in the lipid profile in participants with hypercholesterolemia: Results from a Phase 1 study
3个月前
已关闭
皖公网安备34019202002308
